Cargando…

Molecularly Guided Drug Repurposing for Cholangiocarcinoma: An Integrative Bioinformatic Approach

Background: Cholangiocarcinoma (CCA) has a complex immune microenvironment architecture, thus possessing challenges in its characterization and treatment. This study aimed to repurpose FDA-approved drugs for cholangiocarcinoma by transcriptomic-driven bioinformatic approach. Methods: Cox-proportiona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Venkatraman, Simran, Balasubramanian, Brinda, Pongchaikul, Pisut, Tohtong, Rutaiwan, Chutipongtanate, Somchai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871819/ https://www.ncbi.nlm.nih.gov/pubmed/35205315 http://dx.doi.org/10.3390/genes13020271

Ejemplares similares

RTK25: A Comprehensive Molecular Profiling Strategy in Cholangiocarcinoma Using an Integrated Bioinformatics Approach
por: Balasubramanian, Brinda, et al.
Publicado: (2021)

Transcriptional Regulation of Cancer Immune Checkpoints: Emerging Strategies for Immunotherapy
por: Venkatraman, Simran, et al.
Publicado: (2020)

Co-Clinical Trials: An Innovative Drug Development Platform for Cholangiocarcinoma
por: Balasubramanian, Brinda, et al.
Publicado: (2021)

In Silico Target Identification of Galangin, as an Herbal Flavonoid against Cholangiocarcinoma
por: Balasubramanian, Brinda, et al.
Publicado: (2022)

Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma
por: Balasubramanian, Brinda, et al.
Publicado: (2023)

Role of mTOR inhibitor in cholangiocarcinoma cell progression
por: MOOLTHIYA, PENPAK, et al.
Publicado: (2014)

Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach
por: Janvilisri, Tavan, et al.
Publicado: (2015)

Downregulation of ABCA1 and ABCG1 transporters by simvastatin in cholangiocarcinoma cells
por: Seeree, Pattaya, et al.
Publicado: (2019)

CD24 induces the invasion of cholangiocarcinoma cells by upregulating CXCR4 and increasing the phosphorylation of ERK1/2
por: LEELAWAT, KAWIN, et al.
Publicado: (2013)

Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells
por: Boonsri, Boonyakorn, et al.
Publicado: (2021)

Placenta-Derived Extracellular Vesicles in Pregnancy Complications and Prospects on a Liquid Biopsy for Hemoglobin Bart’s Disease
por: Chaemsaithong, Piya, et al.
Publicado: (2023)

Dysregulation of microRNA in cholangiocarcinoma identified through a meta-analysis of microRNA profiling
por: Likhitrattanapisal, Somsak, et al.
Publicado: (2020)

Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF-α and chemotherapeutic gemcitabine-induced necroptosis
por: Akara-amornthum, Perawatt, et al.
Publicado: (2020)

Gadd45β silencing impaired viability and metastatic phenotypes in cholangiocarcinoma cells by modulating the EMT pathway
por: Myint, Kyaw Zwar, et al.
Publicado: (2018)

Receptor-interacting protein kinase 1 is a key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3 ligand-promoted invasion in cholangiocarcinoma
por: Lomphithak, Thanpisit, et al.
Publicado: (2020)

Integration of genomic variants and bioinformatic-based approach to drive drug repurposing for multiple sclerosis
por: Afief, Arief Rahman, et al.
Publicado: (2022)

Comprehensive Analysis of Imipenemase (IMP)-Type Metallo-β-Lactamase: A Global Distribution Threatening Asia
por: Pongchaikul, Pisut, et al.
Publicado: (2022)

Insights into bioinformatic approaches for repurposing compounds as anti-viral drugs
por: Zheng, Wenxiao, et al.
Publicado: (2021)

Translational Proteomic Approach for Cholangiocarcinoma Biomarker Discovery, Validation, and Multiplex Assay Development: A Pilot Study
por: Watcharatanyatip, Kamolwan, et al.
Publicado: (2022)

WaterMap and Molecular Dynamic Simulation-Guided Discovery of Potential PAK1 Inhibitors Using Repurposing Approaches
por: Biswal, Jayashree, et al.
Publicado: (2021)

Multiplex Biomarker Screening Assay for Urinary Extracellular Vesicles Study: A Targeted Label-Free Proteomic Approach
por: Chutipongtanate, Somchai, et al.
Publicado: (2018)

Red Blood Cell Extracellular Vesicle-Based Drug Delivery: Challenges and Opportunities
por: Chiangjong, Wararat, et al.
Publicado: (2021)

Editorial: Artificial Intelligence in Bioinformatics and Drug Repurposing: Methods and Applications
por: Zheng, Pan, et al.
Publicado: (2022)

Potential drug–drug interactions of frequently prescribed medications in long COVID detected by two electronic databases
por: Meakleartmongkol, Theejutha, et al.
Publicado: (2023)

Systematic comparison of four point-of-care methods versus the reference laboratory measurement of hemoglobin in the surgical ICU setting: a cross-sectional method comparison study
por: Chutipongtanate, Arpa, et al.
Publicado: (2020)

Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches
por: Ahmed, Fee Faysal, et al.
Publicado: (2022)

Genomic variants-driven drug repurposing for tuberculosis by utilizing the established bioinformatic-based approach
por: Irham, Lalu Muhammad, et al.
Publicado: (2022)

Network bioinformatics analysis provides insight into drug repurposing for COVID-19
por: Li, Xu, et al.
Publicado: (2021)

Pathway-Based Drug-Repurposing Schemes in Cancer: The Role of Translational Bioinformatics
por: Hernández-Lemus, Enrique, et al.
Publicado: (2021)

An Integrated Bioinformatics Analysis Repurposes an Antihelminthic Drug Niclosamide for Treating HMGA2-Overexpressing Human Colorectal Cancer
por: Leung, Stephen Wan, et al.
Publicado: (2019)

Transcriptome-Guided Drug Repurposing for Aggressive SCCs
por: Zauner, Roland, et al.
Publicado: (2022)

Potential treatments of COVID-19: Drug repurposing and therapeutic interventions
por: Raghav, Pawan Kumar, et al.
Publicado: (2023)

Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses
por: Li, Guobing, et al.
Publicado: (2020)

Identification of Potential Repurposable Drugs in Alzheimer’s Disease Exploiting a Bioinformatics Analysis
por: Fiscon, Giulia, et al.
Publicado: (2022)

Connecting two worlds: positive correlation between physicochemical approach with blood gases and pH in pediatric ICU setting
por: Chaiyakulsil, Chanapai, et al.
Publicado: (2019)

On the Integration of In Silico Drug Design Methods for Drug Repurposing
por: March-Vila, Eric, et al.
Publicado: (2017)

Inhibition of protein kinase C promotes dengue virus replication
por: Noppakunmongkolchai, Warobon, et al.
Publicado: (2016)

Activation of cannabinoid receptors in breast cancer cells improves osteoblast viability in cancer-bone interaction model while reducing breast cancer cell survival and migration
por: Khunluck, Tueanjai, et al.
Publicado: (2022)

Translational Bioinformatics for Cholangiocarcinoma: Opportunities and Challenges
por: Qian, Fuliang, et al.
Publicado: (2018)

Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review)
por: Chiangjong, Wararat, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v4la636jb72ucql5a26n3o4724